Literature DB >> 8288675

Increase of labeling indices in gastrointestinal mucosae of mice and rats by compounds of the okadaic acid type.

H Yuasa1, K Yoshida, H Iwata, H Nakanishi, M Suganuma, M Tatematsu.   

Abstract

Effects of compounds of the okadaic acid type (okadaic acid, dinophysistoxin-1, calyculin A and tautomycin) on proliferation by digestive-tract epithelial cells were investigated in mice and rats. In mice, a single oral administration of these agents caused significant enhancement of BrdU labeling indices in a dose/response manner. Exceptions showing no response were limited to the pyloric mucosa for okadaic acid, the pyloric and fundic mucosa for calyculin A and the pyloric mucosa for tautomycin. Sequential analysis of labeling indices after a single oral administration of dinophysistoxin-1 revealed two peaks of cell proliferation at 18 h and 36 h in the esophagus, ileum and colon. The labeling indices of the forestomach, fundus, pylorus and jejunum, on the other hand, continuously increased from 6 h after the administration. Elevated proliferation was also observed in the skin after 30 h or after, but no effects on the liver or kidney were evident. A single oral administration of the okadaic acid type of compounds also dose-dependently enhanced cell proliferation of the rat digestive tract. These results strongly suggest that the okadaic acid class of compounds may exert promoting potential for the gastrointestinal mucosa when administered orally.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8288675     DOI: 10.1007/BF01372558

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  15 in total

1.  Structurally different members of the okadaic acid class selectively inhibit protein serine/threonine but not tyrosine phosphatase activity.

Authors:  M Suganuma; H Fujiki; S Okabe; S Nishiwaki; D Brautigan; T S Ingebritsen; M R Rosner
Journal:  Toxicon       Date:  1992-08       Impact factor: 3.033

2.  Differential regulation of jun family gene expression by the tumor promoter okadaic acid.

Authors:  A Schönthal; A S Alberts; J A Frost; J R Feramisco
Journal:  New Biol       Date:  1991-10

Review 3.  Regulation of cell proliferation at the onset of DNA synthesis.

Authors:  A B Pardee; D L Coppock; H C Yang
Journal:  J Cell Sci Suppl       Date:  1986

Review 4.  Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds.

Authors:  H Fujiki; M Suganuma
Journal:  Adv Cancer Res       Date:  1993       Impact factor: 6.242

5.  Calyculin A, an inhibitor of protein phosphatases, a potent tumor promoter on CD-1 mouse skin.

Authors:  M Suganuma; H Fujiki; H Furuya-Suguri; S Yoshizawa; S Yasumoto; Y Kato; N Fusetani; T Sugimura
Journal:  Cancer Res       Date:  1990-06-15       Impact factor: 12.701

6.  Histopathological studies on experimental marine toxin poisoning. I. Ultrastructural changes in the small intestine and liver of suckling mice induced by dinophysistoxin-1 and pectenotoxin-1.

Authors:  K Terao; E Ito; T Yanagi; T Yasumoto
Journal:  Toxicon       Date:  1986       Impact factor: 3.033

7.  The tumor promoters 12-O-tetradecanoylphorbol-13-acetate and okadaic acid differ in toxicity, mitogenic activity and induction of gene expression.

Authors:  H R Herschman; R W Lim; D W Brankow; H Fujiki
Journal:  Carcinogenesis       Date:  1989-08       Impact factor: 4.944

Review 8.  Is the inhibition of protein phosphatase 1 and 2A activities a general mechanism of tumor promotion in human cancer development?

Authors:  H Fujiki
Journal:  Mol Carcinog       Date:  1992       Impact factor: 4.784

9.  Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter.

Authors:  M Suganuma; H Fujiki; H Suguri; S Yoshizawa; M Hirota; M Nakayasu; M Ojika; K Wakamatsu; K Yamada; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

10.  Diarrhetic shellfish toxin, dinophysistoxin-1, is a potent tumor promoter on mouse skin.

Authors:  H Fujiki; M Suganuma; H Suguri; S Yoshizawa; K Takagi; N Uda; K Wakamatsu; K Yamada; M Murata; T Yasumoto
Journal:  Jpn J Cancer Res       Date:  1988-10
View more
  6 in total

1.  Tautomycin: an inhibitor of protein phosphatases 1 and 2A but not a tumor promoter on mouse skin and in rat glandular stomach.

Authors:  M Suganuma; S Okabe; E Sueoka; R Nishiwaki; A Komori; N Uda; K Isono; H Fujiki
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

2.  Okadaic Acid, a Bioactive Fatty Acid from Halichondria okadai, Stimulates Lipolysis in Rat Adipocytes: The Pivotal Role of Perilipin Translocation.

Authors:  Nen-Chung Chang; Aming Chor-Ming Lin; Cheng-Chen Hsu; Jung-Sheng Liu; Leo Tsui; Chien-Yuan Chen; Thanasekaran Jayakumar; Tsorng-Harn Fong
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-10       Impact factor: 2.629

Review 3.  Is protein phosphatase inhibition responsible for the toxic effects of okadaic Acid in animals?

Authors:  Rex Munday
Journal:  Toxins (Basel)       Date:  2013-02-04       Impact factor: 4.546

4.  Oral toxicity of okadaic acid in mice: study of lethality, organ damage, distribution and effects on detoxifying gene expression.

Authors:  Andres C Vieira; Juan A Rubiolo; Henar López-Alonso; José Manuel Cifuentes; Amparo Alfonso; Roberto Bermúdez; Paz Otero; Mercedes R Vieytes; Félix V Vega; Luis M Botana
Journal:  Toxins (Basel)       Date:  2013-11-08       Impact factor: 4.546

5.  Comparative analysis of the cytotoxic effects of okadaic acid-group toxins on human intestinal cell lines.

Authors:  Pierre-Jean Ferron; Kevin Hogeveen; Valérie Fessard; Ludovic Le Hégarat
Journal:  Mar Drugs       Date:  2014-08-21       Impact factor: 5.118

Review 6.  The concept of the okadaic acid class of tumor promoters is revived in endogenous protein inhibitors of protein phosphatase 2A, SET and CIP2A, in human cancers.

Authors:  Hirota Fujiki; Eisaburo Sueoka; Tatsuro Watanabe; Masami Suganuma
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-20       Impact factor: 4.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.